Net revenues increased 30.4% sequentially to $15.0 million, from $11.5 million in the second quarter GAAP net loss for the ...
Highlights Revenue Milestones and Expands Alternative Protein & Pharmaceutical Partnerships with Dapibus™ & C1 Technology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback